Sleep apnea tied to insulin resistance in young, lean men

August 29, 2012
Sleep apnea tied to insulin resistance in young, lean men
In healthy, lean, young men, the presence of obstructive sleep apnea correlates with insulin resistance and compensatory hyperinsulinemia to maintain normal glucose levels, according to a study published online Aug. 21 in Diabetes Care.

(HealthDay)—In healthy, lean, young men, the presence of obstructive sleep apnea (OSA) correlates with insulin resistance and compensatory hyperinsulinemia to maintain normal glucose levels, according to a study published online Aug. 21 in Diabetes Care.

Sushmita Pamidi, M.D., from the University of Chicago, and colleagues conducted a prospective study involving healthy men (age 18 to 30 years; [BMI], 18 to 25 kg/m²) who underwent laboratory polysomnogram followed by a morning . Participants were stratified according to the presence or absence of ethnicity-based diabetes risk and family history of diabetes. Twelve men with OSA were selected and matched with 20 controls without OSA.

The researchers found that age, BMI, ethnicity-based diabetes risk, family history of diabetes, and level of exercise were similar for men with OSA and controls. Normal systolic and diastolic blood pressure and fasting lipid levels were seen in both groups. Despite having comparable glucose levels, men with OSA had 27 percent lower insulin sensitivity (estimated by Matsuda index) and 37 percent higher total , compared with control subjects, after ingestion of glucose load.

"In young, lean, and healthy men who are free of cardiometabolic disease, the presence of OSA is associated with and a compensatory rise in insulin secretion to maintain normal glucose tolerance," the authors write. "OSA may increase the risk of type 2 diabetes independently of traditional cardiometabolic risk factors."

Explore further: Sleep apnea severity linked to glycated hemoglobin levels

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Sleep apnea severity linked to glycated hemoglobin levels

June 18, 2012
(HealthDay) -- For adults without diabetes, obstructive sleep apnea (OSA) severity is independently associated with impaired glucose metabolism, as measured by glycated hemoglobin (HbA1c) levels, according to a study published ...

Liver insulin resistance correlates with cardiac risk

April 16, 2012
(HealthDay) -- Liver insulin resistance (IR) may be a significant indicator of cardiovascular disease (CVD) risk among men, and correlates more closely with risk factors than whole-body insulin sensitivity, according to a ...

Recommended for you

Biochemical 'fingerprints' reveal diabetes progression

August 21, 2017
Researchers from Umeå University in Sweden describe a new method to study biochemical changes that occur in the pancreas during the development of diabetes. The method, recently published in Scientific Reports, is based ...

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.